Page last updated: 2024-11-03

probenecid and Anemia, Hemolytic

probenecid has been researched along with Anemia, Hemolytic in 3 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
JANDL, JH1
Sevitt, S1
Stone, P1
Jackson, D1
Baar, S1
Pollock, A1

Other Studies

3 other studies available for probenecid and Anemia, Hemolytic

ArticleYear
Current concepts in therapy. Hemolytic anemia.
    The New England journal of medicine, 1963, Feb-28, Volume: 268

    Topics: Adrenocorticotropic Hormone; Anemia; Anemia, Hemolytic; Chelating Agents; Cortisone; Erythropoiesis;

1963
Acute Heinz-body anaemia in burned patients.
    Lancet (London, England), 1973, Sep-01, Volume: 2, Issue:7827

    Topics: Adult; Ampicillin; Anemia, Hemolytic; Aspirin; Burns; Carbenicillin; Cloxacillin; Digoxin; Erythrocy

1973
Hemolytic anemia complicating viral hepatitis and G-6-PD deficiency.
    JAMA, 1969, Jun-30, Volume: 208, Issue:13

    Topics: Anemia, Hemolytic; Anemia, Hemolytic, Congenital; Aspirin; Glucosephosphate Dehydrogenase Deficiency

1969